Review



alt-r genome editing detection kit  (Integrated DNA Technologies)


Bioz Verified Symbol Integrated DNA Technologies is a verified supplier
Bioz Manufacturer Symbol Integrated DNA Technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Integrated DNA Technologies alt-r genome editing detection kit
    Alt R Genome Editing Detection Kit, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 92/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Alt-R+Genome+Editing+Detection+Kit/custom%401075931%4042446379
    Average 92 stars, based on 152 article reviews
    alt-r genome editing detection kit - by Bioz Stars, 2026-11
    92/100 stars

    Images

    Related Articles

    Polymerase Chain Reaction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Amplification:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Chloramphenicol Acetyltransferase Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Expressing:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Clone Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Mutagenesis:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Suspension:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Cleavage Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Saline:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Injection:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Infection:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Mouse Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Transfection:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Selection:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Sequencing:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Activity Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Bioprocessing:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Oligomer Restriction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Plasmid Preparation:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Extraction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    FACS:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    DNA Extraction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Western Blot:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    RNA Extraction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Luciferase:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Glutamate Assay:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Real-time Polymerase Chain Reaction:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit

    Electrophoresis:

    Article Title: SLC25A28 is a synthetic lethal vulnerability in nucleotide excision repair-deficient cancers
    Article Snippet: PrePrint: e designed to generate amplicons, with the Cas9 cleavage site placed off-center within the amplicon T7EI-based editing-efficiency detection was performed using the Alt-R™ Genome Editing Detection Kit (Integrated DNA Technologies, Cat #1075931) following the manufacturer’s protocol. Briefly, PCR products were denatured and slowly re-annealed to form wild-type/mutant heteroduplexes, then digested wit



    Similar Products

    96
    Akoya Biosciences opal 7 color ihc kit
    Opal 7 Color Ihc Kit, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Opal+6-Plex+Detection+Kit/pmc13757280-69-52-56
    Average 96 stars, based on 1 article reviews
    opal 7 color ihc kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    Advanced Cell Diagnostics Inc rnascope fluorescent multiplex kit
    Rnascope Fluorescent Multiplex Kit, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/RNAscope+Multiplex+Fluorescent+Detection+Kit+v2/pmc13750795-229-19-23
    Average 99 stars, based on 1 article reviews
    rnascope fluorescent multiplex kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    CapitalBio Corporation deafness gene variant detection array kit
    Deafness Gene Variant Detection Array Kit, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/deafness+gene+variant+detection+array+kit/nct06133946-1-20-26
    Average 90 stars, based on 1 article reviews
    deafness gene variant detection array kit - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    99
    Beyotime mitochondrial membrane potential detection kit
    Mitochondrial Membrane Potential Detection Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/JC-1/pmc13748765-248-15-44
    Average 99 stars, based on 1 article reviews
    mitochondrial membrane potential detection kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Advanced Cell Diagnostics Inc mirnascope 2 5 hd detection reagent red kit
    Mirnascope 2 5 Hd Detection Reagent Red Kit, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/miRNAscope+HD+Detection+Reagents+-+RED/pmc13748923-129-24-35
    Average 99 stars, based on 1 article reviews
    mirnascope 2 5 hd detection reagent red kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Beyotime annexin v fitc pi kit
    Engineering and characterization of the ACGQD@pPLG patch. (A) Representative transmission electron microscopy (TEM) images of CGQD, ApoTK, and ACGQD; scale bars, 25 nm. (B) Fourier transform infrared spectra of glutathione (GSH), GQD, L‐citrulline, and CGQD. (C) X‐ray photoelectron spectroscopy survey spectra of GQD and CGQD. (D) High‐resolution C 1s, N 1s, O 1s, and S 2p spectra of CGQD with fitted components. (E) Illustrative model of the proposed CGQD surface chemistry. (F) <t>Annexin</t> V/propidium iodide flow cytometry of untreated and UV‐treated TDSCs used for membrane preparation. The unsorted UV‐treated population was used for membrane preparation. (G) Representative immunoblots of calreticulin and CD47 in NM, CGQD@NM, ApoTK, and ACGQD; Na + /K + ‐ATPase is the membrane‐protein loading control. NM denotes membranes from untreated TDSCs, and the corresponding densitometry is shown in Figure . (H, I) Confocal images of macrophages exposed to ACGQD (H) or CGQD@NM (I). DAPI, CGQD‐associated fluorescence, and DiD‐labeled membrane are shown in blue, green, and red, respectively; scale bar, 10 µm. (J) Electron paramagnetic resonance spectra at the indicated CGQD concentrations. (K) Scavenging percentages for ABTS• + , DPPH•, O 2 • − , and •OH over the tested CGQD concentration range. (L) TEM images of a core–shell PLG fiber; scale bars, 2 µm and 500 nm. (M) Atomic force microscopy topography of a pPLG fiber; scale bar, 1 µm. (N) Confocal images of fluorescently labeled scaffold fibers (blue), ACGQD (magenta), and the merged view, showing cargo distribution in the cell‐free scaffold. (O) Scanning electron microscopy of randomly oriented PLG (rPLG) and aligned PLG (pPLG) fibers. (P) Color‐enhanced view of aligned pPLG fibers. Scale bars in O and P, 2 µm. (Q) Energy‐dispersive X‐ray spectroscopy maps of C, O, and N in the scaffold. (R) Tensile‐testing setup. (S) Young's modulus (left) and tensile strength (right) of pPLG, ACGQD@pPLG, and PLLA. (T, U) Water‐contact‐angle images before and after plasma treatment (T) and quantification (U). (V) 3D confocal images of TDSCs on pPLG; DAPI, FAK, and F‐actin are shown in blue, green, and red, respectively. Scale bar, 100 µm. Data are mean ± SD; n = 5 specimens per formulation in S and n = 3 for the other quantitative analyses. Comparisons were made by one‐way ANOVA with Tukey's post hoc test (S) or two‐sided Student's t ‐test (U); p values are shown in the panels.
    Annexin V Fitc Pi Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Beyo3D+Annexin+V-FITC+Apoptosis+Detection+Kit/pmc13749005-293-5-8
    Average 99 stars, based on 1 article reviews
    annexin v fitc pi kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Akoya Biosciences opal multiplex ihc kit
    The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), <t>IHC</t> staining (n = 51), and <t>mIHC</t> analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).
    Opal Multiplex Ihc Kit, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Opal+6-Plex+Detection+Kit+-+for+Whole+Slide+Imaging/pmc13748784-208-7-11
    Average 96 stars, based on 1 article reviews
    opal multiplex ihc kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    98
    Cytiva Europe ecl prime detection kit
    The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), <t>IHC</t> staining (n = 51), and <t>mIHC</t> analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).
    Ecl Prime Detection Kit, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Amersham+ECL+Prime+Western+blot+detection+reagent/pmc13744505-70-24-28
    Average 98 stars, based on 1 article reviews
    ecl prime detection kit - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    99
    InvivoGen hek blue lps detection kit
    The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), <t>IHC</t> staining (n = 51), and <t>mIHC</t> analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).
    Hek Blue Lps Detection Kit, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/HEK-Blue+LPS+Detection+Kit+2/pmc13762361-66-21-25
    Average 99 stars, based on 1 article reviews
    hek blue lps detection kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Akoya Biosciences reactive opal fluorophores
    The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), <t>IHC</t> staining (n = 51), and <t>mIHC</t> analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).
    Reactive Opal Fluorophores, supplied by Akoya Biosciences, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/detection+kit/Opal+6-Plex+Detection+Kit/pm42993832-458-38-42
    Average 96 stars, based on 1 article reviews
    reactive opal fluorophores - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Engineering and characterization of the ACGQD@pPLG patch. (A) Representative transmission electron microscopy (TEM) images of CGQD, ApoTK, and ACGQD; scale bars, 25 nm. (B) Fourier transform infrared spectra of glutathione (GSH), GQD, L‐citrulline, and CGQD. (C) X‐ray photoelectron spectroscopy survey spectra of GQD and CGQD. (D) High‐resolution C 1s, N 1s, O 1s, and S 2p spectra of CGQD with fitted components. (E) Illustrative model of the proposed CGQD surface chemistry. (F) Annexin V/propidium iodide flow cytometry of untreated and UV‐treated TDSCs used for membrane preparation. The unsorted UV‐treated population was used for membrane preparation. (G) Representative immunoblots of calreticulin and CD47 in NM, CGQD@NM, ApoTK, and ACGQD; Na + /K + ‐ATPase is the membrane‐protein loading control. NM denotes membranes from untreated TDSCs, and the corresponding densitometry is shown in Figure . (H, I) Confocal images of macrophages exposed to ACGQD (H) or CGQD@NM (I). DAPI, CGQD‐associated fluorescence, and DiD‐labeled membrane are shown in blue, green, and red, respectively; scale bar, 10 µm. (J) Electron paramagnetic resonance spectra at the indicated CGQD concentrations. (K) Scavenging percentages for ABTS• + , DPPH•, O 2 • − , and •OH over the tested CGQD concentration range. (L) TEM images of a core–shell PLG fiber; scale bars, 2 µm and 500 nm. (M) Atomic force microscopy topography of a pPLG fiber; scale bar, 1 µm. (N) Confocal images of fluorescently labeled scaffold fibers (blue), ACGQD (magenta), and the merged view, showing cargo distribution in the cell‐free scaffold. (O) Scanning electron microscopy of randomly oriented PLG (rPLG) and aligned PLG (pPLG) fibers. (P) Color‐enhanced view of aligned pPLG fibers. Scale bars in O and P, 2 µm. (Q) Energy‐dispersive X‐ray spectroscopy maps of C, O, and N in the scaffold. (R) Tensile‐testing setup. (S) Young's modulus (left) and tensile strength (right) of pPLG, ACGQD@pPLG, and PLLA. (T, U) Water‐contact‐angle images before and after plasma treatment (T) and quantification (U). (V) 3D confocal images of TDSCs on pPLG; DAPI, FAK, and F‐actin are shown in blue, green, and red, respectively. Scale bar, 100 µm. Data are mean ± SD; n = 5 specimens per formulation in S and n = 3 for the other quantitative analyses. Comparisons were made by one‐way ANOVA with Tukey's post hoc test (S) or two‐sided Student's t ‐test (U); p values are shown in the panels.

    Journal: Advanced Science

    Article Title: A Citrulline‐Functionalized Patch Coordinates Macrophage NRF2 Signaling and Arginine Metabolism for Tendon‐to‐Bone Repair

    doi: 10.1002/advs.78630

    Figure Lengend Snippet: Engineering and characterization of the ACGQD@pPLG patch. (A) Representative transmission electron microscopy (TEM) images of CGQD, ApoTK, and ACGQD; scale bars, 25 nm. (B) Fourier transform infrared spectra of glutathione (GSH), GQD, L‐citrulline, and CGQD. (C) X‐ray photoelectron spectroscopy survey spectra of GQD and CGQD. (D) High‐resolution C 1s, N 1s, O 1s, and S 2p spectra of CGQD with fitted components. (E) Illustrative model of the proposed CGQD surface chemistry. (F) Annexin V/propidium iodide flow cytometry of untreated and UV‐treated TDSCs used for membrane preparation. The unsorted UV‐treated population was used for membrane preparation. (G) Representative immunoblots of calreticulin and CD47 in NM, CGQD@NM, ApoTK, and ACGQD; Na + /K + ‐ATPase is the membrane‐protein loading control. NM denotes membranes from untreated TDSCs, and the corresponding densitometry is shown in Figure . (H, I) Confocal images of macrophages exposed to ACGQD (H) or CGQD@NM (I). DAPI, CGQD‐associated fluorescence, and DiD‐labeled membrane are shown in blue, green, and red, respectively; scale bar, 10 µm. (J) Electron paramagnetic resonance spectra at the indicated CGQD concentrations. (K) Scavenging percentages for ABTS• + , DPPH•, O 2 • − , and •OH over the tested CGQD concentration range. (L) TEM images of a core–shell PLG fiber; scale bars, 2 µm and 500 nm. (M) Atomic force microscopy topography of a pPLG fiber; scale bar, 1 µm. (N) Confocal images of fluorescently labeled scaffold fibers (blue), ACGQD (magenta), and the merged view, showing cargo distribution in the cell‐free scaffold. (O) Scanning electron microscopy of randomly oriented PLG (rPLG) and aligned PLG (pPLG) fibers. (P) Color‐enhanced view of aligned pPLG fibers. Scale bars in O and P, 2 µm. (Q) Energy‐dispersive X‐ray spectroscopy maps of C, O, and N in the scaffold. (R) Tensile‐testing setup. (S) Young's modulus (left) and tensile strength (right) of pPLG, ACGQD@pPLG, and PLLA. (T, U) Water‐contact‐angle images before and after plasma treatment (T) and quantification (U). (V) 3D confocal images of TDSCs on pPLG; DAPI, FAK, and F‐actin are shown in blue, green, and red, respectively. Scale bar, 100 µm. Data are mean ± SD; n = 5 specimens per formulation in S and n = 3 for the other quantitative analyses. Comparisons were made by one‐way ANOVA with Tukey's post hoc test (S) or two‐sided Student's t ‐test (U); p values are shown in the panels.

    Article Snippet: Apoptosis was assessed with an Annexin V‐FITC/PI kit (Beyotime).

    Techniques: Transmission Assay, Electron Microscopy, Fourier Transform Infrared Spectroscopy, Spectroscopy, Flow Cytometry, Membrane, Western Blot, Control, Confocal, Fluorescence, Labeling, Electron Paramagnetic Resonance, Concentration Assay, AFM Microscopy, Scanning Electron Microscopy, Energy Dispersive X-Ray, Clinical Proteomics, Formulation, Transmission Electron Microscopy

    The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), IHC staining (n = 51), and mIHC analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).

    Journal: Advanced Science

    Article Title: Single‐Cell Map of Early Lung Adenocarcinoma Uncovers Invasion‐Associated Tertiary Lymphoid Structures

    doi: 10.1002/advs.78670

    Figure Lengend Snippet: The single‐cell landscape of human lung GGNs. (A) Schematic overview of the experimental design. Human lung GGNs were subjected to scRNA‐seq (n = 12), TCRβ‐seq (n = 27), IHC staining (n = 51), and mIHC analysis (n = 177). (B) t‐SNE plots showing gene expression of selected markers for the eight major cell types identified by scRNA‐seq analysis. (C) t‐SNE plot showing the eight major cell types identified by scRNA‐seq analysis. Each dot corresponds to a single cell colored by cell type. (D) Representative images of H&E and IHC staining for CD3 (T cell), CD20 (B cell), CD68 (myeloid cell), CD56 (NK cell), and tryptase (mast cell) in a cohort of 51 human lung GGNs. Scale bar, 1 mm. (E) Quantification of CD3+, CD20+, CD68+, CD56+, and tryptase+ cell densities in tumor lesions and normal tissues from a cohort of 51 human lung GGNs. ∗∗∗p < 0.001, two‐sided paired t test with Holm correction. (F) t‐SNE plots illustrating different cell compositions and gene expression profiles from two nodules of an MSLC patient (RJLC13).

    Article Snippet: Multiplex immunohistochemistry (mIHC) was performed using the Opal Multiplex IHC kit (Akoya Biosciences, NEL861001KT) according to the manufacturer's instructions.

    Techniques: Single Cell, Immunohistochemistry, Analysis, Gene Expression

    Tumor infiltration of bystander lymphocytes and immune suppression. (A) t‐SNE plot showing lung‐resident signature scores across all single cells. The red circle highlights T cells. (B) t‐SNE plots showing expression of resident T cell marker genes (top) and circulating T cell marker genes (bottom) across all single cells. Composite signature scores for resident T cells (R3) and circulating T cells (C3) are shown at right. (C) Heatmap of 17 resident and 9 circulating T cell‐related genes comparing resident (R3+C3−) and circulating (R3−C3+) T cell populations. (D) Quantification of resident (green) and circulating (red) T cells in each human lung GGN. (E) TCR frequencies in 22 patients with lung GGNs as categorized into four groups: Tumor unique (only detected in tumor lesions), Tumor/Lung (shared with matched lung tissues), Tumor/PBMC (shared with matched PBMC), and Tumor/Lung/PBMC (shared across all matched samples). (F) Venn diagram showing shared TCR clonotypes in lung GGNs of two MSLC patients (RJLC19 and RJLC23). The pie chart depicts the distribution of shared TCR clonotypes in four categories (Tumor unique, Tumor/Lung, Tumor/PBMC, Tumor/Lung/PBMC). (G) t‐SNE plot showing eight clusters of 25,152 T cells identified by scRNA‐seq analysis from 12 human lung GGNs. Each dot is a single cell colored by cluster. (H) Heatmap showing expression of selected key genes related to T cell function across the eight T‐cell clusters. (I) t‐SNE plot showing eleven clusters of 5,075 myeloid cells identified by scRNA‐seq analysis from 12 human lung GGNs. Each dot is a single cell colored by cluster. (J) Heatmap showing expression of selected checkpoint ligands across the eleven myeloid cell clusters. (K) Representative images of IHC staining for CD3 (T cell), PD‐1, CD68 (myeloid cell), and PD‐L1 in a cohort of 51 human lung GGNs. Scale bar, 50 µm. (L) Quantification of PD‐1+ and PD‐L1+ cell densities in tumor lesions and paired normal tissues from a cohort of 51 human lung GGNs. P values were calculated using two‐sided paired t test.

    Journal: Advanced Science

    Article Title: Single‐Cell Map of Early Lung Adenocarcinoma Uncovers Invasion‐Associated Tertiary Lymphoid Structures

    doi: 10.1002/advs.78670

    Figure Lengend Snippet: Tumor infiltration of bystander lymphocytes and immune suppression. (A) t‐SNE plot showing lung‐resident signature scores across all single cells. The red circle highlights T cells. (B) t‐SNE plots showing expression of resident T cell marker genes (top) and circulating T cell marker genes (bottom) across all single cells. Composite signature scores for resident T cells (R3) and circulating T cells (C3) are shown at right. (C) Heatmap of 17 resident and 9 circulating T cell‐related genes comparing resident (R3+C3−) and circulating (R3−C3+) T cell populations. (D) Quantification of resident (green) and circulating (red) T cells in each human lung GGN. (E) TCR frequencies in 22 patients with lung GGNs as categorized into four groups: Tumor unique (only detected in tumor lesions), Tumor/Lung (shared with matched lung tissues), Tumor/PBMC (shared with matched PBMC), and Tumor/Lung/PBMC (shared across all matched samples). (F) Venn diagram showing shared TCR clonotypes in lung GGNs of two MSLC patients (RJLC19 and RJLC23). The pie chart depicts the distribution of shared TCR clonotypes in four categories (Tumor unique, Tumor/Lung, Tumor/PBMC, Tumor/Lung/PBMC). (G) t‐SNE plot showing eight clusters of 25,152 T cells identified by scRNA‐seq analysis from 12 human lung GGNs. Each dot is a single cell colored by cluster. (H) Heatmap showing expression of selected key genes related to T cell function across the eight T‐cell clusters. (I) t‐SNE plot showing eleven clusters of 5,075 myeloid cells identified by scRNA‐seq analysis from 12 human lung GGNs. Each dot is a single cell colored by cluster. (J) Heatmap showing expression of selected checkpoint ligands across the eleven myeloid cell clusters. (K) Representative images of IHC staining for CD3 (T cell), PD‐1, CD68 (myeloid cell), and PD‐L1 in a cohort of 51 human lung GGNs. Scale bar, 50 µm. (L) Quantification of PD‐1+ and PD‐L1+ cell densities in tumor lesions and paired normal tissues from a cohort of 51 human lung GGNs. P values were calculated using two‐sided paired t test.

    Article Snippet: Multiplex immunohistochemistry (mIHC) was performed using the Opal Multiplex IHC kit (Akoya Biosciences, NEL861001KT) according to the manufacturer's instructions.

    Techniques: Expressing, Marker, Analysis, Single Cell, Cell Function Assay, Immunohistochemistry

    Identification of invasion‐associated TLSs. (A) Radar plot showing the distribution of eight major cell types in human lung GGNs diagnosed with AIS/MIA (n = 6) vs. IAC (n = 6). ∗p < 0.05, two‐sided Mann–Whitney U test with Benjamini–Hochberg adjustment. (B) Representative images of H&E and IHC staining for CD20 (B cell) in human lung GGNs diagnosed with AIS/MIA vs. IAC. Scale bar, 1 mm. (C) Quantification of TLS density in a cohort of 265 human lung GGNs diagnosed with pGGN (n = 162), or mGGN (n = 103). Representative CT images are shown. Yellow arrows indicate GGNs. p value was calculated using two‐sided Mann–Whitney U test. (D) Quantification of TLS density in a cohort of 265 human lung GGNs diagnosed with AIS (n = 55), MIA (n = 88), or IAC (n = 122). P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (E) Quantification of TLS density in pre‐invasive and invasive regions from a cohort of 46 human lung GGNs diagnosed with MIA. Representative images of H&E and IHC staining for CD3 (T cell) and CD20 (B cell) are shown. Scale bar, 250 µm. P values were calculated using two‐sided exact sign test after excluding 16 zero differences. (F) Quantification of TLS density across multiple lesions in a cohort of 17 MSLC patients with lung GGNs. H&E staining for an MSLC patient (RJLC45) with MIA and IAC lesions is shown. Blue arrows indicate TLSs. Scale bar, 1 mm. (G) Sankey diagram showing the distribution of human lung GGNs by CT features, pathology, and TLS density.

    Journal: Advanced Science

    Article Title: Single‐Cell Map of Early Lung Adenocarcinoma Uncovers Invasion‐Associated Tertiary Lymphoid Structures

    doi: 10.1002/advs.78670

    Figure Lengend Snippet: Identification of invasion‐associated TLSs. (A) Radar plot showing the distribution of eight major cell types in human lung GGNs diagnosed with AIS/MIA (n = 6) vs. IAC (n = 6). ∗p < 0.05, two‐sided Mann–Whitney U test with Benjamini–Hochberg adjustment. (B) Representative images of H&E and IHC staining for CD20 (B cell) in human lung GGNs diagnosed with AIS/MIA vs. IAC. Scale bar, 1 mm. (C) Quantification of TLS density in a cohort of 265 human lung GGNs diagnosed with pGGN (n = 162), or mGGN (n = 103). Representative CT images are shown. Yellow arrows indicate GGNs. p value was calculated using two‐sided Mann–Whitney U test. (D) Quantification of TLS density in a cohort of 265 human lung GGNs diagnosed with AIS (n = 55), MIA (n = 88), or IAC (n = 122). P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (E) Quantification of TLS density in pre‐invasive and invasive regions from a cohort of 46 human lung GGNs diagnosed with MIA. Representative images of H&E and IHC staining for CD3 (T cell) and CD20 (B cell) are shown. Scale bar, 250 µm. P values were calculated using two‐sided exact sign test after excluding 16 zero differences. (F) Quantification of TLS density across multiple lesions in a cohort of 17 MSLC patients with lung GGNs. H&E staining for an MSLC patient (RJLC45) with MIA and IAC lesions is shown. Blue arrows indicate TLSs. Scale bar, 1 mm. (G) Sankey diagram showing the distribution of human lung GGNs by CT features, pathology, and TLS density.

    Article Snippet: Multiplex immunohistochemistry (mIHC) was performed using the Opal Multiplex IHC kit (Akoya Biosciences, NEL861001KT) according to the manufacturer's instructions.

    Techniques: MANN-WHITNEY, Immunohistochemistry, Staining, Pathology

    Modulation of TLS maturation. (A) Representative images of mIHC staining of TLSs in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. (B) Quantification of TLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (C) Quantification of iTLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (D) Quantification of mTLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (E) Stacked bar graph showing the proportions of iTLS and mTLS in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. (F) Schematic of the orthotopic murine lung adenocarcinoma model. CT and H&E staining were used to evaluate tumor growth and TLS formation. (G) Representative images of mIHC staining of TLSs in the orthotopic murine lung adenocarcinoma model. Three experimental groups were included: EV (empty vector, n = 5), LIGHT overexpression (n = 5), and LTαβ overexpression (n = 5). (H) Representative images of mIHC staining of TLSs in the orthotopic murine lung adenocarcinoma model. Two experimental groups were included: IgG2a isotype control (n = 5) and anti‐PD‐1 treatment (n = 5). (I) Quantification of TLS density in the orthotopic murine lung adenocarcinoma model. P values were calculated using two‐sided exact Mann–Whitney U test with Holm correction. (J) Stacked bar graph showing the proportions of iTLS and mTLS in the orthotopic murine lung adenocarcinoma model. mTLSs were defined by the presence of a discernible CD21‐positive follicular dendritic cell network. (K) Quantification of tumor size in the orthotopic murine lung adenocarcinoma model. P values were calculated using two‐sided exact Mann–Whitney U test with Holm correction.

    Journal: Advanced Science

    Article Title: Single‐Cell Map of Early Lung Adenocarcinoma Uncovers Invasion‐Associated Tertiary Lymphoid Structures

    doi: 10.1002/advs.78670

    Figure Lengend Snippet: Modulation of TLS maturation. (A) Representative images of mIHC staining of TLSs in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. (B) Quantification of TLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (C) Quantification of iTLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (D) Quantification of mTLS density in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. P values were calculated using two‐sided Mann–Whitney U test with Holm correction. (E) Stacked bar graph showing the proportions of iTLS and mTLS in AIS (n = 32), MIA (n = 38), and IAC (n = 107) from a cohort of 177 human lung GGNs. (F) Schematic of the orthotopic murine lung adenocarcinoma model. CT and H&E staining were used to evaluate tumor growth and TLS formation. (G) Representative images of mIHC staining of TLSs in the orthotopic murine lung adenocarcinoma model. Three experimental groups were included: EV (empty vector, n = 5), LIGHT overexpression (n = 5), and LTαβ overexpression (n = 5). (H) Representative images of mIHC staining of TLSs in the orthotopic murine lung adenocarcinoma model. Two experimental groups were included: IgG2a isotype control (n = 5) and anti‐PD‐1 treatment (n = 5). (I) Quantification of TLS density in the orthotopic murine lung adenocarcinoma model. P values were calculated using two‐sided exact Mann–Whitney U test with Holm correction. (J) Stacked bar graph showing the proportions of iTLS and mTLS in the orthotopic murine lung adenocarcinoma model. mTLSs were defined by the presence of a discernible CD21‐positive follicular dendritic cell network. (K) Quantification of tumor size in the orthotopic murine lung adenocarcinoma model. P values were calculated using two‐sided exact Mann–Whitney U test with Holm correction.

    Article Snippet: Multiplex immunohistochemistry (mIHC) was performed using the Opal Multiplex IHC kit (Akoya Biosciences, NEL861001KT) according to the manufacturer's instructions.

    Techniques: Staining, MANN-WHITNEY, Plasmid Preparation, Over Expression, Control, H&E Stain